Long-Term Survival after T-cell Lymphoblastic Lymphoma Treated with One Cycle of Hyper-CVAD Regimen
Il Hwan Ryu, In Sung Cho, Ah Jeong Ryu, Min Gyu Kim, Jae Woong Jeon, Joo Seok Kim, Jae Joon Lee, Ji Wook Choi, Dong Wook Kang
Cancer Res Treat. 2015;47(1):115-119.   Published online 2014 Aug 25     DOI: https://doi.org/10.4143/crt.2013.122
Citations to this article as recorded by Crossref logo
An aberrant presentation of non-hodgkin’s lymphoma as pus: A curious journey
Mayur Devraj, Chaitanya Kappagantu, Sushma Dugad, Ravidra Shinde, Komal Shah
IP Indian Journal of Immunology and Respiratory Medicine.2023; 7(4): 173.     CrossRef

The Neutrophil to Lymphocyte and Lymphocyte to Monocyte Ratios as New Prognostic Factors in Hematological Malignancies – A Narrative Review

Paulina Stefaniuk, Agnieszka Szymczyk, Monika Podhorecka
Cancer Management and Research.2020; Volume 12: 2961.     CrossRef
T-cell lymphoblastic lymphoma involving the ocular adnexa: report of two cases and review of the current literature
Lucy Sun, Alan H. Friedman, Rand Rodgers, Matthew Schear, Giovanni Greaves, Kathryn B. Freidl
Orbit.2019; 38(5): 412.     CrossRef
Effectiveness of modified hyper‐CVAD chemotherapy regimen in the treatment of adult acute lymphoblastic leukemia: a retrospective experience
Hasan Jalaeikhoo, Mohsen Rajaeinejad, Manoutchehr Keyhani, Mohammad Zokaasadi, Mohammad Mehdi Dehghani Firoozabadi
Cancer Medicine.2018; 7(3): 594.     CrossRef